Skip to navigation Skip to content

News release

Voluntary Recall of five (5) lots of APO-QUETIAPINE XR (quetiapine fumarate extended-release tablets)

Jan 31, 2025

 

January 30, 2025
Apotex Inc. ("Apotex"), in coordination with the Regulatory Operations and Enforcement Branch (ROEB) of Health Canada, is initiating a voluntary TYPE I recall to the Pharmacy Level for five (5) lots of "APO-QUETIAPINE XR (quetiapine fumarate extended-release tablets)".

 

Learn more

Media inquries

Have a question for our media team? Fill out our inquiries form, and we’ll get back to you as soon as possible.

Contact our media team

Latest news